Boston Scientific Corporation
| Location | Marlborough, MA |
| Asset Size | $2.9B |
| Number of Participants | 10,000 or More Participants |
| Business | Medical Devices |
| Participation rate | 93% |
| Avg. deferral rate | 8.5% |
| No. of funds offered | 13 |
| Investment Review | Twice a year |
| True-up feature | No |
| Match Vesting Period | Immediate |
| Eligibility | Immediate |
| Default deferral rate | 2% |
| Default investment | Retail TDF (Index) |
| Auto-escalation | Opt-out |
| Systematic withdrawals | No |
| Fee equalization | No |
| Match Rate | 100% of first 6% of salary |
| % receiving full match | >75% |
| Max Employer Contribution | 6.0% |
| Financial education: | |
| Saving/budgeting | x |
| Investing strategies | x |
| College saving | |
| Credit/debt mgt | x |
| Tax/estate planning | |
| Retiree health costs/savings options | x |
| Recordkeeper | Vanguard |
Get the latest news every weekday